MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-23-2026
HTG Molecular Diagnostics ROE Ratio 2011-2026 | HTGM
Annual ROE Ratio HTG Molecular Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -400.51 | -164.86 | -144.08 | -80.51 | -78.01 | 619.7 | 465.59 | -126.66 | 20.04 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 619.7 | -400.51 | 12.3 |
Quarterly ROE Ratio HTG Molecular Diagnostics
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1602.4 | -537.12 | -567.28 | -207.72 | -130.8 | -73.13 | -106.54 | -106.94 | -117.66 | -88.87 | -105.73 | -113.44 | -116.38 | -91.47 | -112.72 | -110.94 | -87.2 | -53.7 | 65.43 | 464.02 | 532.16 | 549.53 | 842.49 | 552.83 | 108.97 | 55.91 | 32.92 | -283.51 | -107.5 | -40.98 | -36.23 | -7.96 | 19.58 | 14.09 | 4.75 | 5.29 | 4.06 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 842.49 | -1602.4 | -42.01 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B |  USA |
 |
Agilent Technologies
A
|
22.45 | $ 135.53 | 0.11 % | $ 41.2 B | USA |
 |
Celcuity
CELC
|
-176.06 | $ 132.88 | 1.5 % | $ 6.21 B | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 8.53 | -23.77 % | $ 11.3 M | USA |
 |
Castle Biosciences
CSTL
|
-5.13 | $ 21.08 | -4.66 % | $ 611 M | USA |
 |
Aspira Women's Health
AWH
|
0.18 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
89.3 | - | -61.36 % | $ 2.46 M | USA |
 |
Fulgent Genetics
FLGT
|
-5.44 | $ 18.14 | -0.55 % | $ 558 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
419.21 | $ 129.69 | -2.65 % | $ 16.3 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 22.82 | 0.53 % | $ 1.22 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
2.49 | $ 136.07 | -0.53 % | $ 10.7 B |  Irlanda |
 |
Check-Cap Ltd.
CHEK
|
120.45 | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 1.7 | -5.56 % | $ 7.52 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 162.96 | 2.68 % | $ 25.9 B | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 99.3 | -0.32 % | $ 6.7 B | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-656.53 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 180.58 | 1.47 % | $ 24.3 B |  Schweiz |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 180.71 | -0.35 % | $ 8.96 B | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 10.52 | 3.24 % | $ 1.35 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 19.53 | -0.66 % | $ 437 M | USA |
 |
Natera
NTRA
|
-77.62 | $ 223.37 | 4.41 % | $ 22 B | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 447.11 | -0.23 % | $ 12.9 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
-99.46 | $ 3.97 | -5.92 % | $ 368 M | USA |
 |
Personalis
PSNL
|
-31.12 | $ 11.4 | 3.83 % | $ 1.02 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.16 | $ 26.39 | -0.23 % | $ 25 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-113.19 | $ 6.79 | 1.04 % | $ 283 M | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
4.64 | - | - | $ 2.69 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-16.42 | $ 66.87 | -3.13 % | $ 4 B | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.39 | -1.74 % | $ 5.49 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 260.06 | -0.75 % | $ 21.6 B | USA |
 |
Thermo Fisher Scientific
TMO
|
12.55 | $ 492.51 | 1.09 % | $ 186 B | USA |
 |
Trinity Biotech plc
TRIB
|
88.73 | $ 0.7 | -0.16 % | $ 251 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 8.97 | -3.55 % | $ 1.95 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 194.9 | -0.72 % | $ 21.6 B | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |